These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12489325)

  • 41. [An update of Streptococcus pneumoniae: from genomic to clinic].
    Wintenberger C
    Med Mal Infect; 2010 Oct; 40(10):605-9. PubMed ID: 20934286
    [No Abstract]   [Full Text] [Related]  

  • 42. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia.
    Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B
    Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A child with pneumonia caused by a multiresistant pneumococcus].
    Verhoef-Verhage EA; Fleer A
    Ned Tijdschr Geneeskd; 1990 Apr; 134(15):770-2. PubMed ID: 2336115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
    Calvo A; Amores R; Valero E; Sevillano D; Prieto J;
    Rev Esp Quimioter; 2001 Dec; 14(4):345-50. PubMed ID: 11856980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of pneumonias caused by Streptococcus pneumoniae].
    Károlyi A; Krompecher E; Böcskei C
    Orv Hetil; 1987 Jul; 128(29):1544. PubMed ID: 3614916
    [No Abstract]   [Full Text] [Related]  

  • 46. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae].
    Soriano F
    Med Clin (Barc); 1999 Jun; 113(3):103-8. PubMed ID: 10464745
    [No Abstract]   [Full Text] [Related]  

  • 47. [A new antibiotic against respiratory tract infections. More power against pneumococci].
    MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
    [No Abstract]   [Full Text] [Related]  

  • 48. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M
    J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Usefulness of pneumococcal antigen urinary testing in the intensive care unit?
    Camou F; Issa N; Bessede É; Mourissoux G; Guisset O
    Med Mal Infect; 2015 Aug; 45(8):318-23. PubMed ID: 26344817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
    Soriano F; Fernández-Roblas R
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):503-4. PubMed ID: 9011211
    [No Abstract]   [Full Text] [Related]  

  • 51. [Upper respiratory tract infections in the adult, excluding otitis. The clinician's point of view].
    Klossek JM
    Presse Med; 2002 Nov; 31(37 Pt 2):S18-9; discussion S20. PubMed ID: 12489330
    [No Abstract]   [Full Text] [Related]  

  • 52. Pneumonia caused by a pneumococcus resistant to erythromycin and lincomycin. Case report.
    Medoff G
    Mo Med; 1974 Aug; 71(8):496-7. PubMed ID: 4152480
    [No Abstract]   [Full Text] [Related]  

  • 53. A case series of macrolide treatment failures in community acquired pneumonia.
    Iannini PB; Paladino JA; Lavin B; Singer ME; Schentag JJ
    J Chemother; 2007 Oct; 19(5):536-45. PubMed ID: 18073153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Is pneumonia of unknown origin yet a pneumococcal pneumonia sometimes?].
    Boersma WG; Löwenberg A; Koëter GH
    Ned Tijdschr Geneeskd; 1992 Jun; 136(24):1137-40. PubMed ID: 1608479
    [No Abstract]   [Full Text] [Related]  

  • 55. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
    Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
    Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ways of improving the effectiveness of bacteriological diagnosis and treatment of nonspecific lung diseases].
    Kozlova NV; Girshovich ES; Spirina TS
    Antibiot Khimioter; 1990 Aug; 35(8):41-3. PubMed ID: 2264754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones.
    Carratalá J; Martín-Herrero JE; Mykietiuk A; García-Rey C
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():2-11. PubMed ID: 16669924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Croupous pneumonia: current and unresolved aspects].
    Alekseev VG; Kozlovskiĭ IA
    Klin Med (Mosk); 1993; 71(4):61-3. PubMed ID: 8246423
    [No Abstract]   [Full Text] [Related]  

  • 59. Question 3: can pneumonia caused by penicillin-resistant Streptococcus pneumoniae be treated with penicillin?
    Clifford V; Tebruegge M; Vandeleur M; Curtis N
    Arch Dis Child; 2010 Jan; 95(1):73-7. PubMed ID: 20040690
    [No Abstract]   [Full Text] [Related]  

  • 60. [The problem of staphylococcal infections from microbiologist's point of view].
    STASTNA J
    Cesk Pediatr; 1960 Feb; 15():157-62. PubMed ID: 13833890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.